Over the five years to 2015, revenue for the Pharmacy and Drugstore industry has been growing at an annualized rate of 19.1%, and is expected to reach $100.4 billion in 2015. Many factors have supported the development of the industry, including substantial growth in domestic demand for drugs retailed by drugstores, relatively higher drug prices in hospitals and consumers' increased ability to self medicate. Additionally, China's accession to the World Trade Organization in December 2001 and the subsequent entry of foreign investment have boosted industry growth.
The Pharmacy and Drugstore industry in China retails both western medicine and traditional Chinese medicine, products for birth control and sexual healthcare, and other personal and pharmaceutical products.
The report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecast, growth rates and an analysis of the industry key players and their market shares.